(Q44176935)

30 November 2017

AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat. (English)

1 reference

30 November 2017

1 reference

1 reference

1

1 reference

30 November 2017

M L Evans

2

1 reference

30 November 2017

R J Jacob

3

1 reference

30 November 2017

X Fan

4

1 reference

30 November 2017

Y Zhu

5

1 reference

30 November 2017

G I Shulman

6

1 reference

30 November 2017

R S Sherwin

7

1 reference

30 November 2017

language of work or name

1 reference

1 November 2002

1 reference

American Journal of Physiology - Endocrinology and Metabolism

30 November 2017

1 reference

30 November 2017

283

1 reference

30 November 2017

5

1 reference

30 November 2017

E1076-83

1 reference

In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.

30 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Evidence that the brain of the conscious dog is insulin sensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Brain of the conscious dog is sensitive to physiological changes in circulating insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Suppression of counterregulatory hormone response to hypoglycemia by insulin per se.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Novel glucosensor for hypoglycemic detection localized to the portal vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Time course of the defective alpha-cell response to hypoglycemia in diabetic BB rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Diabetogenic action of streptozotocin: relationship of dose to metabolic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Importance of Insulin in Subjective, Cognitive, and Hormonal Responses to Hypoglycemia in Patients With IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Insulin within islets is a physiologic glucagon release inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Abnormal alpha cell function in human diabetes: the response to oral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Hypoglycemia-associated autonomic failure in advanced type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Glucagon response to hypoglycemia is improved by insulin-independent restoration of normoglycemia in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

Glucagon physiology and pathophysiology in the light of new advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00195.2002

10.1152/AJPENDO.00195.2002

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference